Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAT-2054 with Atorvastatin in Hypercholesterolemia
NCT02608697Phase 2Completed
- Sponsor
- Astria Therapeutics
- Start
- Oct 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CAT-2054 in hypercholesterolemia, sponsored by Astria Therapeutics. Started Oct 2015; status: completed.
02
Drugs
CAT-2054
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02608697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02608697.